Akebia Therapeutics, Inc.
AKBA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1 | $0 | $6 | -$23 |
| Dep. & Amort. | $0 | $0 | $0 | $14 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $0 | $2 | $0 |
| Change in WC | $19 | $5 | -$30 | -$3 |
| Other Non-Cash | $5 | $17 | $8 | $8 |
| Operating Cash Flow | $28 | $22 | -$14 | -$4 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | $0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $10 | -$1 |
| Stock Issued | $0 | $2 | $65 | $22 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $0 | $1 |
| Financing Cash Flow | $1 | $2 | $75 | $22 |
| Forex Effect | $0 | -$0 | $0 | -$0 |
| Net Chg. in Cash | $29 | $24 | $62 | $18 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $139 | $113 | $54 | $34 |
| End Cash | $168 | $137 | $115 | $52 |
| Free Cash Flow | $28 | $22 | -$14 | -$4 |